Been piecing this together and figured it was worth a post. Two things a lot of people get wrong: what’s actually behind the recent export-side seizure wave out of China, and what “US warehouse” really means when sellers advertise it.
Why China is cracking down on exports right now
Three things stacked together:
-Patent politics. The core GLP-1 compound patent in China expired March 20, 2026. Domestic biosimilar makers are just now ramping up legitimate production. Authorities have every reason to crack down on gray-market exporters undercutting the newly-legal domestic industry and still infringing on patents in destination countries like the US, where the patent runs until 2033.
-Diplomatic pressure. Major Western pharma companies have secured ITC exclusion orders targeting counterfeit imports. An INTERPOL operation from Dec 2024 to May 2025 ran across 90 countries including China, netting hundreds of arrests. Big pharma is pushing through diplomatic channels and China has reasons to look cooperative.
-Domestic scandal prevention. Probably the biggest driver. Chinese authorities are scared of counterfeit product killing people domestically, which would be a political disaster right as the legit domestic industry is launching. Cracking down on export labs disrupts the same operations serving the Chinese gray market.
Retail sales of this stuff are still technically illegal inside China outside licensed channels, which is why most of the overseas-facing activity specifically targets foreign buyers.
What a “US warehouse” actually is
Nothing like a mainstream fulfillment service.
Almost always a small third-party reshipping operation. Sometimes a legit bonded warehouse storing pallets for multiple overseas clients in an industrial unit. Sometimes a garage, residential address, or rented storage space run by a paid US-based contractor. Range is huge, down to a guy’s spare bedroom.
Workflow: seller bulk-ships via air or ocean freight with a US importer of record on paper. Once cleared, it sits at the domestic node. You order, operator prints a domestic label and drops it in the mail. Looks domestic, 2 to 5 days.
This space skews informal because mainstream fulfillment companies drop the account once they realize what’s in the boxes. A lot of actual warehousing is legit cross-border e-commerce operators quietly taking one gray client on the side.
Do multiple sellers share the same warehouse?
All the time. A single operator might fulfill for 5 to 20+ clients at once. Two competing “brands” can easily ship from the same building, sometimes the same shelf. Segregation is only as clean as the operator. A pro setup with warehouse management software keeps it straight; a guy in a storage unit with a spreadsheet is grabbing from whichever bin is closer.
If two sellers source from the same Chinese lab and fulfill from the same US operator, you’re literally getting identical product with different labels at different prices. Also explains why “our US warehouse is down” outages often hit multiple brands at once. One raid takes down many.
Seller and US agent trust
Shakiest part of the setup. Agent doesn’t hold leverage, they don’t own the inventory and can be swapped. But their exposure is real: name on the lease, address that could get raided. Motivated not to skim (ongoing payout beats one-time grab) but motivated to bail fast if law enforcement sniffs around. If an agent steals, seller has zero recourse.
What holds it together: reputation in the logistics network (word travels fast), hometown/clan ties for some, staggered payments so the agent’s always owed something, and running multiple agents in parallel to absorb losses.
Makers vs. middlemen
Most misunderstood piece. A minority (usually bigger, longer-running operations) are actual makers or tight with one specific lab. Real synthesis, own quality control, own vialing, consistent quality, can do custom orders. Most are resellers, sourcing from one or more Chinese labs, rebranding, switching suppliers on price. Quality drifts batch to batch. Middle category: started as middlemen, got close enough to one lab to be effectively vertically integrated.
Signals closer to a real maker: batch-specific lab reports, consistent purity and identity data across orders, non-catalog items on request, answers technical questions directly. Signals middleman: catalog mirrors other sellers, inconsistent presentation, “let me check with the lab,” labels and fill quality change between orders.
US legal side, briefly
Nothing here is a scheduled controlled substance, so possession isn’t a drug crime. But under federal law anything intended for human use that isn’t approved is technically an unapproved new drug, and selling for human consumption is illegal. “Research use only” is essentially fiction. Regulators look at how the product is actually marketed. Buyers at personal-use quantities basically never get prosecuted. Sellers are where enforcement ramped hard in 2025 to 2026.
The question: how much should “has US domestic stock” factor into trust?
Some value to it. A stocked node proves they’ve cleared customs at least once, rules out pure fly-by-night. And domestic shipping kills customs risk on your package regardless of quality. But the signal’s weaker than it looks: warehouse photos are easily faked, shared warehouses obscure whose inventory is whose, international freight and the last-mile domestic label are totally different skills, and the “US contact” is a paid contractor who burns out or disappears.
Domestic stock is mostly (a) customs insurance for you and (b) weak signaling of real infrastructure. The actual reliability predictors (years operating, recent consistent reviews, responsive comms, clean reship history) come from reputation, not stock status.